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Towards the Prediction of Antimicrobial Efficacy for
Hydrogen Bonded, Self-Associating Amphiphiles
Nyasha Allen,[a] Lisa J. White+,[b] Jessica E. Boles+,[b] George T. Williams,[b] Dominique F. Chu,[c]
Rebecca J. Ellaby,[b] Helena J. Shepherd,[b] Kendrick K. L. Ng,[b] Laura R. Blackholly,[a, b]
Ben Wilson,[a, b] Daniel P. Mulvihill,*[a] and Jennifer R. Hiscock*[b]
Herein we report 50 structurally related supramolecular self-
associating amphiphilic (SSA) salts and related compounds.
These SSAs are shown to act as antimicrobial agents, active
against model Gram-positive (methicillin-resistant Staphylococ-
cus aureus) and/or Gram-negative (Escherichia coli) bacteria of
clinical interest. Through a combination of solution-state, gas-
phase, solid-state and in silico measurements, we determine 14
different physicochemical parameters for each of these 50
structurally related compounds. These parameter sets are then
used to identify molecular structure-physicochemical property-
antimicrobial activity relationships for our model Gram-negative
and Gram-positive bacteria, while simultaneously providing
insight towards the elucidation of SSA mode of antimicrobial
action.
Introduction
Since the discovery of the first antibiotic, humanity has relied
heavily upon antimicrobial agents to combat and/or prevent
communicable bacterial diseases or infections. Unfortunately,
bacterial strains have now been identified which are resistant to
all antimicrobial agents currently marketed.[1] This includes the
antibiotic of last resort – colistin[2] – and commonly used
antiseptics such as octenidine.[3]
A recent report commissioned by the UK government has
predicted that the number of global annual deaths directly
attributed to antimicrobial resistance (AMR) is set to rise from
0.7 million (2014) to 10 million (2050), overtaking those directly
attributed to cancer. Although AMR is a global issue of high
importance, the effects will be most felt in developing countries
located in Africa and Asia.[4] To curb the rise of AMR, great
efforts have been made to improve antimicrobial/antibiotic
stewardship.[5] This includes the removal of antibiotics from
animal feedstuffs[6] and the intelligent prescription of antibiotics
by both clinicians[7] and veterinarians,[8] combined with anti-
biotic susceptibility testing pre-treatment.[9] However, the
discovery of novel antimicrobial agents with potential for
development as antibiotics remains unmet, mainly because of
the cost involved in drug discovery in combination with poor
market returns.[1,10]
In response to this need new strategies towards antimicro-
bial agents have been developed, including those inspired by
supramolecular chemistry. Discoveries in this area include an
example from M. Zhang et al., who have utilised the pillar[5]
arene scaffold to produce synthetic channels capable of
selectively inserting into bacterial membranes and demonstrat-
ing efficacy against Gram-positive Staphylococcus epidermidis.[11]
Furthermore, El-Sheshtawy et al., have demonstrated the ability
of cucurbit[7]uril to extend both the shelf-life and antimicrobial
activity of fluoroquinolone antibiotics, through the formation of
inclusion complexes.[12] In addition, a neutral pyridyl urea
scaffold developed by Gunnlaugsson et al., has been shown to
self-associate and form supramolecular gels, which demonstrate
antimicrobial activity against both Gram-positive Methicillin-
Resistant Staphylococcus aureus (MRSA) and Gram-negative
Escherichia coli (E. coli).[13]
To date our work on this topic has focused on the
development of a novel class of Supramolecular Self-associating
Amphiphile (SSA) such as those illustrated in Figure 1 and
Table 1.[14–18] Members from this class of compound have also
been identified as antimicrobial agents against both Gram-
positive and Gram-negative bacteria.[19–21] In this work, we now
expand our initial SSA library and combine low-level computa-
tional modelling and physicochemical self-associative property
determination towards the elucidation of SSA structure-phys-
icochemical property-antimicrobial activity relationships against
Gram-positive (MRSA) and/or Gram-negative (E. coli) bacteria of
clinical interest.[22] This has resulted in the production of
predictive models to drive the intelligent design of ever more
effective, next generation SSA technologies.
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The library of SSAs and related compounds 1–50 were designed
through stepwise alteration of 1, to enable the elucidation of
SSA structure-physicochemical property-antimicrobial activity
relationships. The syntheses of 1–13, 19–39 and 46 have
previously been reported,[14,16–19] while 47–50 were obtained
from commercial sources. Compound 14 was obtained via
cation exchange from 15; however, it was found to be unstable
and so was not used in any further studies. Compound 15 was
obtained as a white solid in a 65% yield through the reaction of
4-(trifluoromethyl) phenyl isothiocyanate with aminomethane-
sulfonic acid in pyridine. Compounds 16–18 were obtained
through the addition of one equivalent of the appropriate
quaternary ammonium hydroxide to 15 in H2O and isolated as
white solids in yields of 98%, 99%, and 88% respectively.
Compounds 40–45 were synthesised through the reaction of
the appropriate tetrabutylammonium (TBA) amino sulfonate
salt with the appropriate isocyanate or isothiocyanate in
pyridine or chloroform and obtained in yields of 63%, 73%,
56%, 32%, 64%, and 58% respectively, as either viscous oils
(40–44) or a cream solid (45).
Antimicrobial activity
Most amphiphilic antimicrobials in use are cationic in nature
and include a wide variety of natural and synthetic scaffolds
such as peptides (polymyxin)[23] and antiseptics (octenidine and
chlorohexidine).[24] Here the targeting of these agents towards
bacteria over mammalian cells is largely driven by electrostatic
interactions between the antimicrobial agent and the nega-
tively charged bacterial surface.[25] Conversely, the more active
portion of the SSA construct is often the anionic component.
The selectivity of the SSA anion towards bacterial membranes is
thought to be due to preferential host:guest complexation
events between the SSA and those phospholipid head groups
present in higher proportions at the surface of bacteria,
compared to eukaryotic cells. Evidence supporting this hypoth-
esis was provided through the completion of an NMR nanodisc
study, in which selective adhesion of 39 to model bacterial over
eukaryotic cell membranes was observed.[26]
Expanding our proof-of-principle antimicrobial efficacy
studies, MIC50 (Minimum Inhibitory Concentration required to
decrease microbial growth by 50%) values were determined for
compounds 1–50 which passed initial antimicrobial screening,
were an agent was found to decrease microbial growth by>
10% after 15 hours when supplied to the microbial culture at
Figure 1. Chemical structures of 1–50. For the substituents of individual
compounds 1–33 please refer to Table 1. TMA= tetramethylammonium,
TEA= tetraethylammonium, TPA= tetrapropylammonium, TBA= tetrabuty-
lammonium.
Table 1. Substituents for the general chemical structure shown in Figure 1,
giving rise to compounds 1–33.
SSA R1 R2 X n A Z
1 CF3 H O 1 SO3
  TBA
2 CF3 H O 2 SO3
  TBA
3 CF3 H O 3 SO3
  TBA
4 CF3 H S 1 SO3
  TBA
5 CF3 H S 2 SO3
  TBA
6 CF3 H S 3 SO3
  TBA
7 CF3 H O 1 SO3
  Na+
8 CF3 H O 1 SO3
  PyrH+
9 CF3 H O 1 SO3
  TMA
10 CF3 H O 1 SO3
  TEA
11 CF3 H O 1 SO3
  TPA
12 CF3 H O 1 SO3
  TPeA
13 CF3 H O 1 SO3
  THA
14 CF3 H S 1 SO3
  Na+
15 CF3 H S 1 SO3
  PyrH+
16 CF3 H S 1 SO3
  TMA
17 CF3 H S 1 SO3
  TEA
18 CF3 H S 1 SO3
  TPA
19 NH2 H O 1 SO3
  TBA
20 OMe H O 1 SO3
  TBA
21 H H O 1 SO3  TBA
22 NO2 H O 1 SO3
  TBA
23 H CF3 O 1 SO3
  TBA
24 OMe H S 1 SO3
  TBA
25 H H S 1 SO3  TBA
26 NO2 H S 1 SO3
  TBA
27 H CF3 S 1 SO3
  TBA
28 CF3 H O 1 CO2
tBu N/A
29 CF3 H O 1 COOH N/A
30 CF3 H O 1 COO
  TBA
31 CF3 H S 1 CO2
tBu N/A
32 CF3 H S 1 COOH N/A
33 CF3 H S 1 COO  TBA
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3.3 mM.[27] The results of these microbial studies are summar-
ised in Table 2.
The molecular structures of compounds 1–50 have been
designed using a stepwise approach to the alteration of SSA 1.
For example, 2 and 3 enable us to gain an understanding of the
effects of increasing the distance between the urea and anionic
group. Compounds 4–6 then allow observation of the effect of
altering the lipophobicity and hydrogen bond donating and
accepting properties of the urea as opposed to the thiourea
group. In a similar fashion changing the SSA R groups (19–27)
and, substitution of the phenyl ring system for a butyl chain
(40–45) allows us to understand the effects of substituting
electron withdrawing/donating (hydrogen bond activating/
deactivating moieties) or hydrophobic/hydrophilic units to the
SSA structure. To investigate the effects of the counter cation
on SSA properties compounds 7–18 and 47–50 were obtained
while, 28–33 were design to enable investigation of the effects
of the SSA anion. Finally, 34–39 facilitate the exploration of
multiple aromatic ring system addition to the core SSA
structure while, 38, 39 and 46 allow us to understand the
effects of covalently linking the thio/urea array to the SSA
anion.
The majority of SSAs were synthesised as the TBA salt
however, simple TBA salts are known to exhibit some antimicro-
bial effects[28] and therefore, the antimicrobial efficacy of SSAs
1–46 was compared against that of TBACl (50). These data are
presented in Figure 2 and show that the presence of the SSA
counter anion results in increased antimicrobial activity against
MRSA (1, 2, 4–6, 8–11, 16, 17, 19–25, 27, 30, 32–39, 41, 43, 44
and 46) and E. coli (1–3, 6, 11, 30, 34, 38 and 39). Of these SSAs,
5 or 16 (MIC50=0.25 mM and 0.27 mM respectively) and 30
(MIC50=1.25 mM) were identified as the most effective anti-
microbial agents against MRSA and E. coli, respectively. Addi-
tionally, 30 was identified to be the most effective broad
spectrum antimicrobial SSA, demonstrating comparable activity
against both model Gram-negative and Gram-positive bacteria.
As mentioned previously, the structure of the SSA anion has
been designed to selectively interact with specific phospholipid
head groups. Further evidence supporting the tailorable
selectivity of SSA technologies towards different cell mem-
branes can also be found through comparison of the antimicro-
bial activity data shown in Table 2 and Figure 2. For example,
these data show 8 to be an effective antimicrobial against
MRSA but not E. coli. However, the reverse is true for 3. Given
this evidence, it is also plausible to hypothesise that, through
structural variation of the SSA construct, membrane selectivity
may be further fine-tuned to produce SSA candidates that
preferentially interact with different types of bacterial cell
membranes. It is known that the phospholipid composition of
bacterial membranes differ between microbial species.[29,30]
Further evidence to support this hypothesis was obtained when
ranking the five most effective antimicrobial SSAs against MRSA
(5�16>8>11>1=35) and E. coli (30>3>6>38>1). Here
the order of SSA efficacy was found to differ significantly for the
model Gram-positive, which contains a high proportion of
phosphatidylglycerol – PG (57%) but no phosphatidylethanol-
amine (PE) and Gram-negative bacteria, which contains a high
proportion of PE (85%) compared to PG (15%).[30]
Table 2. Overview of MIC50 values (mM) determined for 1–50 against clinically relevant Gram-positive MRSA USA300 and Gram-negative E. coli DH10B at an
initial calibrated cell concentration equal to the 0.5 McFarland standard, after 900 mins. Fail=compound failed initial antimicrobial screening. Ratio=MIC50
MRSA: MIC50 E. coli. Ampicillin was used as a control to test the validity of the antimicrobial MIC50 determination methods.
SSA MRSA E. coli ratio SSA MRSA E. coli ratio
1[21] 0.46 3.85[a] 1 : 8.4 26 [b] [b] N/A
2 0.98 3.93[a] 1 : 4.0 27 1.10[d] Fail N/A
3 [b] 1.48[a] N/A 28 [b] [b] N/A
4 3.03 [b] N/A 29 Fail Fail N/A
5 0.25 [b] N/A 30 1.14 1.25 1 :1.1
6 1.08 1.85[a] 1 : 1.7 31 [b] [b] N/A
7 Fail Fail N/A 32 0.83 Fail N/A
8 0.35 Fail N/A 33 0.77 Fail N/A
9 2.17 10.8[a] 1 : 5.0 34 2.45 4.30[a] 1 : 1.8
10 2.85 Fail N/A 35[19] 0.46 [b] N/A
11 0.42 5.96[a] 1 : 14 36[19] 0.61 Fail N/A
12 [b] [b] N/A 37[19] 0.71 Fail N/A
13 [b] [b] N/A 38[d][21] 0.99 3.57[a] 1 : 3.6
14 [c] [c] N/A 39[d][21] 0.93 5.02[a] 1 : 5.4
15 Fail Fail N/A 40 4.41 Fail N/A
16 0.27 Fail N/A 41 2.85 5.67[a] 1 : 2.0
17 0.92 Fail N/A 42 5.78 [b] N/A
18 5.10 Fail N/A 43 3.07 6.03[a] 1.96
19 3.00 Fail N/A 44 2.78 Fail N/A
20 1.53 Fail N/A 45 8.99 6.91[a] 1:0.8
21 0.98 [b] N/A 46 3.12 6.26[a] 1 : 2.0
22 2.59 [b] N/A 47 Fail Fail N/A
23 1.65[d] Fail N/A 48 Fail Fail N/A
24 1.96 8.65[a] 1 : 4.4 49 Fail Fail N/A
25 2.24 7.37[a] 1 : 3.3 50 3.18 6.36[a] 1 : 2.0
Ampicillin 0.0003 0.003 1 :10
[a] Endpoint of experiment predicted due to compound solubility. [b] MIC50 value greater than compound solubility. [c] SSA unstable in solution. [d] Clouding
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It is also known that the phospholipid membrane composi-
tion of bacteria alters depending on factors such as stage of life
cycle[31] and growth phase, ergo this ranking may change
depending on these factors.[32] The results of initial compound
antimicrobial screening assays, as highlighted in Figure 3,
provides evidence for this. Here, Figure 3a shows that the
addition of an SSA to MRSA immediately affects log phase
growth where that compound is found to exhibit antimicrobial
activity. However, in analogous antimicrobial efficacy experi-
ments conducted against E. coli (Figure 3b), the antimicrobial
effect of an SSA is only observed after�600 mins, as the
microbial culture enters the stationary phase. Therefore,
although MRSA is susceptible to SSAs during log-phase, the
susceptibility of E. coli towards SSAs was found to increase as
the bacteria enters stationary phase.
Microscopy studies
We have previously shown that SSA 39, when supplied to the
cell culture as a 5% EtOH solution, is presented at the cell
surface as a spherical aggregate.[21] This SSA was then shown to
coat the surface of MRSA and E. coli, before being internalised.
Using FM 4-64,[33] a fluorescent non-selective lipid binding
molecule (Figure 4), competitive membrane association assays
were carried out with SSA 39, to further probe the coordination
of SSAs to these bacterial membranes.
These competitive fluorescence microscopy studies were
undertaken with both Gram-negative (E. coli) and Gram-positive
(MRSA) bacteria. Within the scope of these studies, the effects
of both SSA 39 and FM 4-64 addition (when added to the cell
culture alone or in combination) were studied. As shown in
Figure 5, these two molecules fluoresce at different wave-
Figure 2. Antimicrobial efficacy of 1–50 against model bacteria. Dashed lines
indicate the activity of control compound 50 (TBACl) against those same
model organisms.
Figure 3. Example screening data obtained for SSAs at 3.3 mM against a)
MRSA USA300 and b) E. coli DH10B at an initial calibrated cell concentration
equal to the 0.5 McFarland standard. Control data demonstrates normal
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lengths, allowing both molecules to be visualised independ-
ently of one another during the experiment. Within the scope
of these fluorescence microscopy experiments, a 450 nm filter
was used to visualise 39 and a 605 nm filter was used to
visualise FM 4-64 (Figures 5 and 6). In the absence of 39, FM 4-
64 can clearly be observed binding to the microbial membrane
(Figure 5b) however, when 39 is added to a bacterial sample
already stained with FM 4-64 (Figure 5d and Figure 6), there is a
decrease in the fluorescence of FM 4-64 to a background level.
This shows 39 to have outcompeted the FM 4-64, previously
bound to the microbial membrane. In order to confirm these
observations, comparison of the proportions of FM 4-64 and 39
associated/interacting with the bacteria were performed
through quantitative microscopy analysis.[34] The results of this
comparison are summarised in Figure 7. Here we compare the
average fluorescence intensity observed under each filter
(450 nm and 605 nm) for>30 cells under the experimental
conditions described in Figures 5 and 6 and the Supporting
Information.
After 4 hours in the presence of 39 this SSA is observed to
have internalized within both MRSA and E. coli. Interestingly,
although the morphology of the E. coli cells (Figure 8a) remains
similar to the untreated cells seen in Figure 5a, there is a
pronounced effect on the morphology of the MRSA cells
(Figure 8b). Here there is an apparent loss of membrane
Figure 4. Non-selective, styryl lipid membrane binding dye, FM 4-64.
Figure 5. Fluorescence images of E. coli: a) in the absence of any compound;
b) incubated with membrane binding compound FM 4-64 (shown in red) for
30 mins; c) incubated with SSA 39 (shown in blue) for 30 mins; d) incubated
initially with FM 4-64 (1 min) followed by the addition of 39 (for 30 mins).
Scale bar: 10 μm, fluorescence images produced using a 450 nm or a 605 nm
filter.
Figure 6. Microscopy images of MRSA in the presence of 39 and FM 4-64 in
combination at T=30 min. This sample was incubated initially with FM 4-64
for 1 min before the addition of 39. Scale bars=10 μm, fluorescence images
produced using a 450 nm filter or a 605 nm filter.
Figure 7. Fluorescence intensity of a) MRSA USA300 cells and b) E. coli
DH10B cells measured at both 450 nm (blue) and 605 nm (pink) in the
absence of FM 4-64 or 39 (solvent alone) or the presence of 39, FM 4-64 or a
combination of 39 and FM 4-64. Results obtained at time T=30 mins. Where
both FM 4-64 and 39 are present, 39 was added 1 min after the addition of
FM 4-64 (T=0 mins). Error=one standard deviation. All quantitative analysis




5ChemMedChem 2020, 15, 1–14 www.chemmedchem.org © 2020 Wiley-VCH GmbH
These are not the final page numbers! ��
Wiley VCH Freitag, 16.10.2020


























































integrity, evidenced by the loss of individual cell definition and
regular cell shape. This difference in cell morphology over time
offers a potential explanation for the five-fold enhancement in
the efficacy of 39 against MRSA over E. coli (Figure 2 and
Table 2).
Physicochemical property overview
We have previously hypothesised that SSA antimicrobial activity
is linked to SSA physicochemical properties, resulting from
molecular structure. It is envisioned that the effective elucida-
tion of molecular structure-physicochemical property-antimicro-
bial activity relationships will allow the informed design of ever-
more effective next generation SSAs, whilst also providing
further insights into SSA mode of antimicrobial action. The
physicochemical data collected for 1–50, was used in the
production of the 14 parameter datasets listed in Table 3. These
data include measurements from solution state, solid state, gas
phase, and in silico studies. Details of which are supplied within
the Supporting Information and summarised where relevant in
Tables 4 and 5.
The anionic portion of an SSA salt contains an uneven
number of hydrogen bond donating and hydrogen bond
accepting functionalities. This means the anionic unit can access
multiple self-associative binding modes simultaneously. How-
ever, we have previously shown the binding modes for this
class of amphiphilic salt to be cation-dependent within the solid
state.[18] Here, the self-associated binding modes of SSAs are
observed using single crystal X-ray diffraction techniques.� To
date we have observed three different self-associative binding
modes for the anionic component of an SSA which are as
follows: 1) thio/urea-anion hydrogen bonded dimers (observed
for 1–4, 6, 11, 18–23, 26–27, 34, 37–39); 2) thio/urea-anion
hydrogen bonded tapes (observed for 5, 8, 17, 30); 3) and thio/
urea-thio/urea hydrogen bonded stacks (observed for 7, 9, 29,
32).[14–19] These different hydrogen bonding modes are exempli-
fied by the novel structures shown in Figure 9. Within Figure 9
each hydrogen bond is shown as a red dashed line however, for
further crystallographic images or structural information please
refer to the Supporting Information. Here, 11 and 18 form thio/
urea-anion hydrogen bonded dimers (Figures 9a and b), 17 was
found to form a thiourea-sulfonate hydrogen bonded tape
(Figure 9c), while 29 and 32 were found to form thio/urea-thio/
urea hydrogen bonded stacks (Figures 9d and e).
Gas phase characterisation of SSA self-association
Consistent with solid state analysis, gas phase studies also
demonstrate the presence of SSA anion dimeric species for the
Figure 8. a) The morphology of E. coli cells in the presence of 39 at T=4 hrs.
b) The morphology of MRSA and E. coli cells in the presence of 39 at
T=4 hrs. Scale bars=10 μm, fluorescence images produced using a 450 nm
filter.
Table 3. List of parameters (P) used in the search of SSA molecular structure-physicochemical property-antimicrobial activity relationships. The data for P2
was transferred into binary values for this portion of the study: no=0; yes=1.
P Parameter description Unit
P1 Molar mass Gmol  1
P2 SSA dimer in the gas phase (e.g. Table 3) N/A
P3 Dimerisation constant – kdim (e.g. Table 3) M  1
P4 Self-associated aggregate size (e.g. Table 3) nm
P5 Zeta potential (e.g. Table 3) mV
P6 CMC (e.g. Table 3) mM
P7 Surface tension at CMC (e.g. Table 3) mNm  1
P8 % of SSA to become NMR silent (e.g. Table 4) %
P9 Emin of SSA anionic component (e.g. Figure 10) kJmol
  1
P10 Emax of SSA anionic component (e.g. Figure 10) kJmol
  1
P11 LogP of SSA anionic R group N/A
P12 Emin of SSA cationic component kJmol
  1
P13 Emax of SSA cationic component kJmol
  1
P14 LogP of SSA cationic R group N/A
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majority of 1–45 (Supporting Information and Table 4). How-
ever, where the anionic portion of the SSA is protected, or
where intramolecular hydrogen bonding events weaken the
formation of any potential self-associative complexes (28, 31
and 38), dimerisation is not observed.
Solution state characterisation of SSA self-association
Characterising SSA self-association events in the solution state
is complex and requires a combination of complementary
techniques. To aid these efforts, each SSA was studied in two
different solvent systems, enabling us to unpick individual
association events from the more complex extended aggregate
formation. In [D6]DMSO, unless specifically stated, the results of
Table 4. Overview of relevant self-associative data generated for 1–6, 8–11, 14–18, 23, 27 and 40–50 from: gas phase high resolution ESI – ve mass
spectrometry studies (presence of SSA anion dimer: Y=yes); solution state 1H NMR dilution studies conducted in a [D6]DMSO/0.5% H2O mixture at 25 °C to
enable the calculation of dimerisation constants (kdim);
[36] solution state characterization of those self-associated aggregates formed in an EtOH/H2O 1 :19
solution through DLS size, zeta potential stability and tensiometry CMC and surface tension at CMC measurements. A full data table for 1–50 can be found
in the Supporting Information.
SSA Gas phase dimer kdim
[M  1]
Size [nm] Zeta potential [mV] CMC [mM] Surface tension [mN m  1]
1[14] Y 2.7 164   76 10.4 37.45
2[14] Y 0.1 459   78 10.7 38.49
3[14] Y 3.3 122   94 8.9 36.78
4[14] Y [c] 295   92 24.1 34.35
5[14] Y 0.2 142   34 6.1 42.24
6[14] Y 2.6 122   38 5.6 33.59
8[14] Y [a] 220   28 198.4 36.16
9[14] Y 6.7[b] 164   24 210.0 41.78
10[14] Y 3.2 190   26 103.1 33.75
11[14] Y 3.3 190   48 34.6 36.09
14 Y N/A N/A N/A N/A N/A
15 Y [c] 235   21 29.0 30.25
16 Y [c] [g]   19 82.3 31.62
17 Y [c] 160 [g] 85.7 33.00
18 Y [c] 192 [g] 17.3 37.73
23 Y 63.7 182   57 3.7 28.65
27 Y [c] [f] [f] [f] [f]
40 Y <0.1 208   38 69.7 42.85
41 Y [d] 174   28 44.9 42.10
42 Y [e] 248   29 60.5 48.92
43 Y [c] 220   37 38.4 39.55
44 Y [d] 121   30 59.6 41.38
45 Y [e] 153   35 66.5 40.79
46 N/A N/A N/A N/A N/A N/A
47 N/A N/A N/A N/A N/A N/A
48 N/A N/A N/A N/A N/A N/A
49 N/A N/A N/A N/A N/A N/A
50 N/A N/A [g] [g] 198.0 37.10
[a] Multiple association event prevents data fitting. [b] Data should be treated with caution as multiple self-association events suspected. [c] Slow exchange
event prevented data fitting. [d] Overall change in chemical shift<0.01 ppm indicating no complex formation. [e] NH resonances could not be observed. [f]
Could not be calculated due to compound solubility. [g] Could not be determined due to lack of reproducibility.
Table 5. Overview of results from quantitative 1H NMR studies. Values given represent the % of compound to become NMR silent in [D6]DMSO/1% CH2Cl2









1[14] 0 51 36[19] 15[b] 92
4[14] 0 50 37[19] 0 34
15 0 46 39[16] 0 10
16 0 48 40 0 56
17 0 55 41 0 41
18 0 55 42 0 43
23 0 76 43 0 47
27 0 [a] 44 0 48
30[14] 0 68 45 0 59
33[14] 0 59 50 0 47
35[16] 0 77
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quantitative 1H NMR§, 1H NMR self-association constant determi-
nation and 1H NMR DOSY experiments (Tables 4 and 5) support
the formation of hydrogen bonded dimers whereas, in a 5%
aqueous ethanol solution SSAs are found to form larger self-
associated aggregates (Supporting Information and Tables 4–5).
Although there are distinct differences in the self-associative
events taking place within the two different solvent systems,
we have previously shown a correlation between the strength
of SSA dimerisation (obtained for SSAs within a [D6]DMSO/0.5%
H2O solution at 25 °C§§) and Critical Micelle Concentration (CMC)
(established for SSAs in a H2O/EtOH 19 :1 solution).
[14,16] Addi-
tional analysis performed to further characterise the self-
associated SSA aggregates formed within a 19 :1 H2O/EtOH
solution includes the use of microscopy[16] and dynamic light
scattering (DLS), to establish aggregate size and/or shape, and
zeta potential measurements to establish aggregate stability
(Table 4 and Supporting Information).
Supporting our previous results,[14,16,19] the hydrodynamic
diameter of the self-associated aggregates formed from 15–18,
23 and 40–45 at 5.56 mM in a 19 :1 H2O/EtOH solution at 25 °C,
obtained from DLS intensity distribution maxima were found to
range between 150–250 nm. Complimentary zeta potential
measurements performed under the same experimental con-
ditions showed aggregates produced via the self-association of
thiourea-based SSAs 15–18 to form less stable structures than
those of the analogous urea-based SSAs 8–11. The presence of
more strongly coordinating counter cations (15–18) was also
shown to result in less stable aggregates relative to the
analogous TBA SSA (4). Increasing the acidity of the hydrogen
bond donor groups through the addition of two (23) rather
than a single (1) CF3 functionality was also shown to destabilise
the aggregates formed. We hypothesise that this may be due to
steric effects caused by the addition of a second bulky CF3
moiety to the phenyl ring system. The addition of a second CF3
functionality was also found to decrease the CMC from
10.39 mM to 3.39 mM, and the surface tension at CMC from
37.49 mN m  1 to 28.65 mN m  1, for 1 and 23 respectively. This
is attributed to the comparative hydrophobicity of the two
phenyl ring systems and increased strength of hydrogen
bonded self-association (kdim=2.7 M
  1 and 63.7 M  1 for 1 and
23 respectively).
The presence of the more strongly coordinating tetraalky-
lammonium ions in 16 and 17, and the replacement of aromatic
ring system(s) with butyl chains, was also found to cause a
comparative increase in CMC and surface tension measure-
ments (40–45) when compared to 1. It is presumed that this is
due to the weakening of the self-associated hydrogen bonded
complex through competitive interactions (16 and 17), a
decrease in cation hydrophobicity (16 and 17), or the
deactivation of the thio/urea hydrogen bond donor groups
(40–45).
In silico characterisation of SSA self-association
Expanding upon work by Hunter[37] and Stuart,[38] our previous
studies indicate that parameter sets derived from electrostatic
Figure 9. Single crystal X-ray structure (obtained via slow evaporation of a
MeOH/H2O solution of the appropriate SSA) of: a) 18, illustrating dimerisation
through urea-anion complexation. TPA counter cations have been omitted
for clarity. Internal angle of dimerisation=179.9 °; b) 11, illustrating
dimerisation through urea-anion complexation and further association
through bridging water molecules. Internal angle of dimerisation=84.7 °.
TPA counter cations have been omitted for clarity; c) 17, illustrating
dimerisation through urea-anion complexation. TEA counter cations have
been omitted for clarity; d) 32, illustrating complexation through thiourea-
thiourea hydrogen bonding. Red=oxygen, blue=nitrogen, green= fluorine,
yellow= sulfur, grey=carbon, white=hydrogen; e) 29, illustrating complex-
ation through urea-urea stacking and carboxylic acid-carboxylic acid hydro-
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potential maps (Figure 10) (P9, P10, P12 and P13) and
calculated LogP values (P11 and P14) for an SSA anion could be
used to predict experimentally derived physicochemical proper-
ties for SSAs such as dimerisation constants (P3 – Table 4) and
CMC values (P6 – Table 4).[14,16] In line with these findings, we
hypothesise that these parameters (P9-P14) may also be used
to describe self-associative non-covalent complex formation
and membrane permeation, and thus inform antimicrobial
activity. To explore this possibility, analogous parameters for 1–




With antimicrobial efficacy for 1–50 (Table 2) established
against model Gram-positive and/or Gram-negative organisms,
SSA structure-physicochemical property-antimicrobial activity
relationships were established for MRSA and E. coli, using the
physicochemical parameters (P1-P14) listed in Table 3. When
investigating MIC50 values generated for 1–50 against E. coli, a
decreasing CMC was found to correlate with decreasing MIC50
value to�11 mM and�5 mM respectively (Figure 11a). There-
fore, we define the SSA critical CMC value required for the
greatest antimicrobial activity against E. coli to be achieved to
be<11 mM. This suggests that for E. coli, SSAs may need to
self-assemble to be active. However, most of the MIC50 values
measured for SSAs 1–45 are lower than the corresponding CMC
value determined for the same SSA. This may be explained by
observations that show CMC values measured in the absence of
other species can be lowered by the presence of biological
targets.[39] The only compound which is shown to deviate
substantially from the correlation depicted in Figure 11a is 50.
However, 50 is the TBACl control, added to this series of
molecules to allow us to establish the antimicrobial activity of
the cationic component common to most SSAs. It is therefore
expected that this salt will not adopt the same mechanism of
action as SSAs 1–45. Interestingly, no analogous correlation
could be identified when comparing CMC values to MIC50 values
generated for MRSA (Figure 11b). This supports the observa-
tions made when comparing those data presented in Table 2
and Figures 2–3, which suggest a different mode of action and
therefore a dependence on different individual physicochemical
SSA properties when considering the efficacy of an SSA towards
either MRSA or E. coli.
For those SSAs which demonstrated both an antimicrobial
activity against E. coli and a CMC<11 mM (1–3, 6, 30, 34, 38,
39), the MIC50 values for these SSAs were further correlated
against the remaining parameters P1–P14 (excluding P6 –
CMC). The most favorable results from these correlation studies
are detailed in Figure 12. Here we see correlations with: zeta
potential – P5 (Figure 12a) which is directly related to SSA
aggregate stability; LogP of the SSA cationic group – P9
(Figure 12b), which we have shown to be influential in SSA
Figure 10. Example electrostatic surface potential map calculated for 41
using Spartan'16, optimised geometries and semi-empirical PM6 modelling
methods. Emax (blue) and Emin (red) values depicted in the figure legend are
given in kJ mol  1 and represent the principle hydrogen bond donating (the
most positively charged point on the surface of an SSA) and accepting (the
most negatively charged point on the surface of an SSA) groups
respectively.
Figure 11. a) Correlations identified for the activity of 1–3, 6, 9, 11, 24, 25,
30, 34, 38, 39, 41, 43, 45 and 50 against E. coli with CMC. Points outlined in
green indicate the point at which decreasing CMC (<1 mM) no longer
relates to decreasing MIC50. Red values indicate potential outliers where
differing properties may affect MIC50 values. Here potential outliers were
identified as those points which deviated the most from the correlation. b)
Comparative scatter plot showing a lack of correlation between the efficacy
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aggregate stability; and Emax of SSA anionic component – P10
(Figure 12c), which is a computer model generated parameter
we have previously shown to correlate directly to the strength
of SSA self-association[16] and CMC.[14] Interestingly, the SSAs
which exhibit the greatest activity against E. coli (30 and 3)
deviate the most from the correlations depicted in Figures 12a
and 12c respectively. We therefore hypothesise that this defines
the correlation shown in Figure 12b as the most accurate model
to aid in the predictive design of next generation SSAs, with
enhanced antimicrobial efficacy towards E. coli using physico-
chemical parameters P1–P14.
Exhaustive search methods
As no correlation could be determined for any single parameter
(P1–P14) and the MIC50 values determined for 1–50 against
MRSA, we extended our search to establish SSA structure-
physicochemical property-antimicrobial activity relationships to
include multiple parameters. Here correlations were identified
by an exhaustive search of models and possible combinations
of parameters. Using the R data analysis software,[40] we
completed two types of model searches. Firstly, we searched all
possible linear models involving up to four of the parameters
listed in Table 3 (Eq. 1). Secondly, we searched all possible
combinations of multiplicative models involving two (Eq. 2) and
three parameters (Eq. 3).
MIC50 ¼ a � PWþb � PXþc � PYþd � PZ (1)
MIC50 ¼ a � PX�PY (2)
MIC50 ¼ a � PX�PY�PZ (3)
The result of the automated searches for model Eq. 1 which
yielded the highest R2 value (see Supporting Information), were
found to incorporate parameters P8§ (% of SSA to become NMR
silent), P10 (Emax of SSA anionic component), and P11 (LogP of
SSA anionic R group). Of the compounds included, 4, 18, 42, 45,
and 50 were shown to deviate the most from the trend
identified. As previously discussed, 50 is a control compound,
so deviation from this correlation is expected. Both compounds
42 and 45 possess a similar chemical structure, so this may
provide supporting evidence that these butyl appended SSAs,
which contain a propyl spacer between the thio/urea and
anionic units, may adopt a different mode of antimicrobial
action. However, there is no clear reason as to why 4 and 18
should also deviate from that correlation identified, meaning
that this model may not be the most reliable of those
identified.
From all fits to Eq. 2 and 3, the parameter combinations
which exhibited the three highest R2 values (Figure 13) were
those with three parameters and, most importantly, all incorpo-
rate P6 (CMC). Although no direct correlation could be
identified when directly comparing CMC to MIC50 values
generated for MRSA (Figure 11b), these complex correlations
identified using the exhaustive search methods reinforce the
Figure 12. Correlations identified for the activity of 1–3, 6, 30, 34, 38 and 39
against E. coli with: a) P5 (zeta potential); b) P9 (Emin of SSA anionic
component); and c) P10 (Emax of SSA anionic component). Red values
indicate potential outliers where differing properties may affect MIC50 values.
Here potential outliers were identified as those points which deviated the
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importance of this parameter towards increasing the efficacy of
SSAs against MRSA. These results also suggest that SSAs may
need to be self-assembled in order to exhibit antimicrobial
efficacy. The correlation identified in Figure 13a includes 1, 2,
4–6, 8–11, 16–18, 20–25, 30, 34–45 and 50 and represents the
most inclusive relationship identified using the data available.
Here compounds 18, 22, 45 and 50 are found to deviate the
most from the calculated correlation. Interestingly 18, 45 and
50 were also identified as outliers when fitting these data to
model Eq. 1, while 22 was excluded from this previous
correlation. This is further supportive evidence that these
compounds may elicit an antimicrobial effect through a differ-
ent mode of action.
Figure 13b shows a correlation between P4 (self-associated
aggregate size), P6 (CMC) and P8 (% of SSA to become NMR
silent) and includes MIC50 values generated against MRSA for 1,
4, 17, 18, 23, 30 and 35–45. Again, 18 and 45 are found to
deviate the most from the correlation identified. However, in
this instance, 17 is also observed to deviate from this
correlation. The final correlation shown in Figure 13c incorpo-
rates P5 (zeta potential), P6 (CMC) and P8 (% of SSA to become
NMR silent) and 1, 4, 16, 23 and 35–45. In this example, three
SSAs (4, 16 and 40) were identified as potential outliers from
this correlation. Although 16 is the only SSA analyzed in this
way which does not contain a TBA cation, 4 and 40
demonstrate little structural similarity. In summary, although
there are six different parameters used to produce the three
models detailed in Figure 13, all of the parameters are directly
related to the effective formation and/or stability of self-
associated spherical aggregates within an aqueous solution as
demonstrated within our previous work.[14] However, our initial
work to investigate SSA membrane association events also
indicated that phospholipid selective interactions are likely to
play a role in SSA antimicrobial activity. This is a factor that is
not taken into account within the scope of these studies.[26]
Conclusions
In previous work we developed first generation predictive
models to derive SSA CMC and dimerisation values using in
silico parameters, generated through low-level computational
modelling.[14,16] We have now extended this initial work,
establishing the antimicrobial activity of compounds 1–50
against model Gram-positive (MRSA) and Gram-negative (E. coli)
bacteria. By expanding our previous library of compounds, we
have been able to build structure-activity models from 14
physiochemical parameters for the first time. This has also
enabled us to gain a greater level of antimicrobial mechanistic
insight. In addition, the use of fluorescence microscopy to
perform competitive membrane binding assays has offered
further evidence that SSAs are able to bind to the bacterial
membrane. These experiments also offered an explanation as to
why the MIC50 value for compound 39 is five times greater for
Gram-negative E. coli than for Gram-positive MRSA.
In initial mode of action and physicochemical-antimicrobial
activity analysis we demonstrated the potential of predictive
models to develop this class of antimicrobial agents, aided
through the exploitation of accessible, low-level computational
Figure 13. Correlations identified for the activity of 1–50 against MRSA with
parameters P1-P14 demonstrating the highest R2 values, generated using
Eq. 2 and 3. Red values indicate potential outliers where differing properties
may affect MIC50 values. P4=Self-associated aggregate size; P5=zeta
potential; P6=CMC; P8=% of SSA to become NMR silent; P11=LogP of
SSA anionic R group; P14=LogP of SSA cationic R group. Here potential
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modelling. Specifically, a correlation was identified between the
CMC>11 mM in EtOH/H2O 1: 19 of 1–50 and MIC50 against E.
coli. Below this CMC value parameters relating to the stability of
aggregate formation were found to predominate. Thus, we
propose that SSAs may need to be self-assembled into larger
structures to optimise antimicrobial activity and, through the
enhancement of complementary phospholipid/self-associative
hydrogen bonding modes, we will be able to enhance the
antimicrobial activity and specificity of future SSA generations.
High throughput automated correlation analysis of the MIC50
values generated against MRSA indicates that physicochemical
parameters associated with the formation and stability of SSA
aggregates are also correlated to the antimicrobial activity
against this strain of bacteria. However, these relationships
appear at present to be more complex than those associated
with E. coli.
Finally, it is hoped that future utilisation of the next-
generation antimicrobial predictive technologies discussed
herein will help to guide the design of novel supramolecular
cell surface agents in the fight against AMR, reducing the
restrictions placed on antimicrobial drug development, through
the lowering of associated costs. Future work in this area is
already underway, focusing on investigating the cytotoxicity of
SSAs toward human cells as well as the elucidation of
pharmacokinetic and pharmacodynamic properties of lead
compounds. The results of these studies will feed into the work
discuss herein to produce ever more effective, next-generation
SSAs that we hope to become pharmacologically relevant.
Notes
� A suitable crystal of each amphiphile was selected and
mounted on a Rigaku Oxford Diffraction Supernova diffractom-
eter. Data were collected using Cu Kα radiation at 100 K.
Structures were solved with the ShelXT[41] or ShelXS structure
solution programs via Direct Methods and refined with
ShelXL[42] on Least Squares minimisation. Olex2[43] was used as
an interface to all ShelX programs. CCDC deposition numbers
for those structures shown in Figure 9=1935640–1935643 and
1935562.
§ Quantitative 1H NMR studies conducted with SSAs in both
[D6]DMSO/CH2Cl2 99 :1 (�112 mM) and D2O/EtOH 19 :1 (
�5.56 mM) indicate the presence of any large self-associated
aggregates in solution. Since the proportion of SSA employed
in the construction of any large aggregates adopts solid-like
characteristics, meaning that it becomes NMR silent in the
solution state, although it is also important to note that
exchange dynamics in and out of the assembly will also play a
role in whether the NMR signals can be seen. Comparative
integration with an internal standard (CH2Cl2 and EtOH
respectively) allows quantification of the percentage of SSA
apparently ‘lost’ from the NMR experiment. The results of
experiments conducted for a representative group of SSAs are
summarised in Table 4.
§§ Proton NMR dilution studies in [D6]DMSO/0.5% H2O at
25 °C (Table 3) were performed in order to quantify the
comparative strength of SSA hydrogen bonded dimerisation,
through fitting to self-associative isotherms using BindFit
v0.5.[36]
§§§ Additional Emax and Emin values were calculated for both
the cationic and anionic components of unpublished molecules
14–18, 23, 27, 40–50 from electrostatic surface potential maps
produced using Spartan'16 and optimised geometries and
semi-empirical PM6 modelling methods. Additional LogP values
for those same compounds calculated for the phenyl or alkyl
substituent attached to the terminal end of the thio/urea
functional group of the anionic component for the respective
SSA and the cationic component separately using Spartan'16
and optimised geometries at the PM6 level.
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The antimicrobial efficacy of 50
supramolecular self-associating salts
(SSAs) and related compounds was
established against MRSA and E. coli.
In addition, 14 different physico-
chemical properties were determined
experimentally for each compound
within this library. From these data
we identified relationships between
compound structure, physiochemical
property, and antimicrobial activity.
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